{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:40:49Z","timestamp":1792669249726,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"DOI":"10.1007\/s00134-026-08628-7","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:04:05Z","timestamp":1792667045000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Principles of drug dosing for obese patients in the intensive care unit"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9054-8218","authenticated-orcid":false,"given":"Jeffrey F.","family":"Barletta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8909-9921","authenticated-orcid":false,"given":"Brian L.","family":"Erstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"issue":"10431","key":"8628_CR1","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/s0140-6736(23)02750-2","volume":"403","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2024","unstructured":"NCD Risk Factor Collaboration (NCD-RisC) (2024) Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet 403(10431):1027\u20131050. https:\/\/doi.org\/10.1016\/s0140-6736(23)02750-2","journal-title":"Lancet"},{"issue":"2","key":"8628_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40262-023-01213-x","volume":"62","author":"D Morales Castro","year":"2023","unstructured":"Morales Castro D, Dresser L, Granton J, Fan E (2023) Pharmacokinetic alterations associated with critical illness. Clin Pharmacokinet 62(2):209\u2013220. https:\/\/doi.org\/10.1007\/s40262-023-01213-x","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"8628_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/10600280221097968","volume":"57","author":"BL Erstad","year":"2023","unstructured":"Erstad BL, Nix DE (2023) Considerations when using body mass index as a size descriptor. Ann Pharmacother 57(1):107\u2013109. https:\/\/doi.org\/10.1177\/10600280221097968","journal-title":"Ann Pharmacother"},{"key":"8628_CR4","unstructured":"CDC. Adult BMI Categories. March 19, 2024. https:\/\/www.cdc.gov\/bmi\/adult-calculator\/bmi-categories.html#:~:text=kg\/m2)-,Underweight,40%20or%20greater (Accessed December 18, 2025)"},{"issue":"3","key":"8628_CR5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/s2213-8587(24)00316-4","volume":"13","author":"F Rubino","year":"2025","unstructured":"Rubino F, Cummings DE, Eckel RH, Cohen RV, Wilding JPH, Brown WA et al (2025) Definition and diagnostic criteria of clinical obesity. Lancet Diab Endocrinol 13(3):221\u2013262. https:\/\/doi.org\/10.1016\/s2213-8587(24)00316-4","journal-title":"Lancet Diab Endocrinol"},{"key":"8628_CR6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/ajhp\/zxaa022","volume":"77","author":"C Eastman","year":"2020","unstructured":"Eastman C, Erstad BL (2020) Availability of information for dosing commonly used medications in special ICU populations. Am J Health Syst Pharm 77:529\u2013534. https:\/\/doi.org\/10.1093\/ajhp\/zxaa022","journal-title":"Am J Health Syst Pharm"},{"key":"8628_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2022.154105","volume":"71","author":"JF Barletta","year":"2022","unstructured":"Barletta JF, Erstad BL (2022) Pitfalls and pearls with drug dosing in the critically ill obese patient: 10 statements to guide ICU practitioners. J Crit Care 71:154105. https:\/\/doi.org\/10.1016\/j.jcrc.2022.154105","journal-title":"J Crit Care"},{"issue":"1","key":"8628_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/ncp.10230","volume":"34","author":"MS Mundi","year":"2019","unstructured":"Mundi MS, Patel JJ, Martindale R (2019) Body composition technology: Implications for the ICU. Nutr Clin Pr 34(1):48\u201358. https:\/\/doi.org\/10.1002\/ncp.10230","journal-title":"Nutr Clin Pr"},{"issue":"2","key":"8628_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/ajhp\/zxac283","volume":"80","author":"BL Erstad","year":"2023","unstructured":"Erstad BL, Romero AV, Barletta JF (2023) Weight and size descriptors for drug dosing: Too many options and too many errors. Am J Health Syst Pharm 80(2):87\u201391. https:\/\/doi.org\/10.1093\/ajhp\/zxac283","journal-title":"Am J Health Syst Pharm"},{"issue":"10","key":"8628_CR10","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.2165\/00003088-200544100-00004","volume":"44","author":"S Janmahasatian","year":"2005","unstructured":"Janmahasatian S, Duffull SB, Ash S, Ward LC, Byrne NM, Green B (2005) Quantification of lean bodyweight. Clin Pharmacokinet 44(10):1051\u20131065. https:\/\/doi.org\/10.2165\/00003088-200544100-00004","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"8628_CR11","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/j.1875-9114.2012.01108.x","volume":"32","author":"MP Pai","year":"2012","unstructured":"Pai MP (2012) Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults. Pharmacotherapy 32(9):856\u2013868. https:\/\/doi.org\/10.1002\/j.1875-9114.2012.01108.x","journal-title":"Pharmacotherapy"},{"issue":"9","key":"8628_CR12","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1345\/aph.19381","volume":"34","author":"MP Pai","year":"2000","unstructured":"Pai MP, Paloucek FP (2000) The origin of the \u201cideal\u201d body weight equations. Ann Pharmacother 34(9):1066\u20131069. https:\/\/doi.org\/10.1345\/aph.19381","journal-title":"Ann Pharmacother"},{"issue":"9","key":"8628_CR13","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1016\/j.clnu.2022.07.032","volume":"41","author":"M Co\u00ebffier","year":"2022","unstructured":"Co\u00ebffier M, El Machkouri M, L\u2019Huillier C, Folope V, Lelandais H, Grigioni S et al (2022) Accuracy of bioimpedance equations for measuring body composition in a cohort of 2134 patients with obesity. Clin Nutr 41(9):2013\u20132024. https:\/\/doi.org\/10.1016\/j.clnu.2022.07.032","journal-title":"Clin Nutr"},{"issue":"3","key":"8628_CR14","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/ejcn.2016.256","volume":"71","author":"AG Dulloo","year":"2017","unstructured":"Dulloo AG, Jacquet J, Miles-Chan JL, Schutz Y (2017) Passive and active roles of fat-free mass in the control of energy intake and body composition regulation. Eur J Clin Nutr 71(3):353\u2013357. https:\/\/doi.org\/10.1038\/ejcn.2016.256","journal-title":"Eur J Clin Nutr"},{"issue":"6","key":"8628_CR15","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1016\/j.chest.2021.08.001","volume":"160","author":"MR Anderson","year":"2021","unstructured":"Anderson MR, Shashaty MGS (2021) Impact of Obesity in Critical Illness. Chest 160(6):2135\u20132145. https:\/\/doi.org\/10.1016\/j.chest.2021.08.001","journal-title":"Chest"},{"issue":"12","key":"8628_CR16","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/ajhp\/zxae317","volume":"82","author":"WL St Peter","year":"2025","unstructured":"St Peter WL, Bzowyckyj AS, Anderson-Haag T, Awdishu L, Blackman M, Bland A et al (2025) Moving forward from Cockcroft-Gault creatinine clearance to race-free estimated glomerular filtration rate to improve medication-related decision-making in adults across healthcare settings: A consensus of the National Kidney Foundation Workgroup for Implementation of Race-Free eGFR-Based Medication-Related Decisions. Am J Health Syst Pharm 82(12):644\u2013659. https:\/\/doi.org\/10.1093\/ajhp\/zxae317","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"8628_CR17","first-page":"8","volume":"37","author":"M Kotlyar","year":"1999","unstructured":"Kotlyar M, Carson SW (1999) Effects of obesity on the cytochrome P450 enzyme system. Int J Clin Pharm Ther 37(1):8\u201319","journal-title":"Int J Clin Pharm Ther"},{"issue":"2","key":"8628_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.5492\/wjccm.v4.i2.139","volume":"4","author":"BL Erstad","year":"2015","unstructured":"Erstad BL (2015) Designing drug regimens for special intensive care unit populations. World J Crit Care Med 4(2):139\u2013151. https:\/\/doi.org\/10.5492\/wjccm.v4.i2.139","journal-title":"World J Crit Care Med"},{"issue":"3","key":"8628_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1365-2125.2011.04089.x","volume":"73","author":"EJ Begg","year":"2012","unstructured":"Begg EJ, Chin PK (2012) A unified pharmacokinetic approach to individualized drug dosing. Br J Clin Pharm 73(3):335\u2013339. https:\/\/doi.org\/10.1111\/j.1365-2125.2011.04089.x","journal-title":"Br J Clin Pharm"},{"issue":"7","key":"8628_CR20","doi-asserted-by":"publisher","first-page":"642","DOI":"10.2146\/ajhp080200","volume":"66","author":"JA Demirovic","year":"2009","unstructured":"Demirovic JA, Pai AB, Pai MP (2009) Estimation of creatinine clearance in morbidly obese patients. Am J Health Syst Pharm 66(7):642\u2013648. https:\/\/doi.org\/10.2146\/ajhp080200","journal-title":"Am J Health Syst Pharm"},{"issue":"15","key":"8628_CR21","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1093\/ajhp\/zxac058","volume":"79","author":"BL Erstad","year":"2022","unstructured":"Erstad BL, Barletta JF (2022) Implications of obesity for drug administration and absorption from subcutaneous and intramuscular injections: A primer. Am J Health Syst Pharm 79(15):1236\u20131244. https:\/\/doi.org\/10.1093\/ajhp\/zxac058","journal-title":"Am J Health Syst Pharm"},{"issue":"Suppl 2","key":"8628_CR22","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1002\/jcph.2361","volume":"63","author":"KT Moore","year":"2023","unstructured":"Moore KT, Zannikos PN, Masters JC, Willmann S, Shen J, Frost C (2023) The importance of assessing drug pharmacokinetics and pharmacodynamics in the obese population during drug development. J Clin Pharm 63(Suppl 2):S78\u2013s84. https:\/\/doi.org\/10.1002\/jcph.2361","journal-title":"J Clin Pharm"},{"issue":"9","key":"8628_CR23","doi-asserted-by":"publisher","first-page":"e504","DOI":"10.1016\/s1473-3099(25)00155-0","volume":"25","author":"AG M\u00e4rtson","year":"2025","unstructured":"M\u00e4rtson AG, Barber KE, Crass RL, Hites M, Kloft C, Kuti JL et al (2025) The pharmacokinetics of antibiotics in patients with obesity: a systematic review and consensus guidelines for dose adjustments. Lancet Infect Dis 25(9):e504\u2013e515. https:\/\/doi.org\/10.1016\/s1473-3099(25)00155-0","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"8628_CR24","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","volume":"46","author":"MH Abdul-Aziz","year":"2020","unstructured":"Abdul-Aziz MH, Alffenaar JC, Bassetti M, Bracht H, Dimopoulos G, Marriott D et al (2020) Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#. Intensive Care Med 46(6):1127\u20131153. https:\/\/doi.org\/10.1007\/s00134-020-06050-1","journal-title":"Intensive Care Med"},{"issue":"8","key":"8628_CR25","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1001\/jama.2024.9779","volume":"332","author":"JM Dulhunty","year":"2024","unstructured":"Dulhunty JM, Brett SJ, De Waele JJ, Rajbhandari D, Billot L, Cotta MO et al (2024) Continuous vs Intermittent \u03b2-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial. Jama 332(8):629\u2013637. https:\/\/doi.org\/10.1001\/jama.2024.9779","journal-title":"Jama"},{"issue":"4","key":"8628_CR26","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/ccm.0000000000007075","volume":"54","author":"HC Prescott","year":"2026","unstructured":"Prescott HC, Antonelli M, Alhazzani W, M\u00f8ller MH, Alshamsi F, Azevedo LCP et al (2026) Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2026. Crit Care Med 54(4):725\u2013812. https:\/\/doi.org\/10.1097\/ccm.0000000000007075","journal-title":"Crit Care Med"},{"issue":"7","key":"8628_CR27","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1097\/ccm.0000000000003779","volume":"47","author":"KA Corl","year":"2019","unstructured":"Corl KA, Prodromou M, Merchant RC, Gareen I, Marks S, Banerjee D et al (2019) The restrictive IV fluid trial in severe sepsis and septic shock (RIFTS): A randomized pilot study. Crit Care Med 47(7):951\u2013959. https:\/\/doi.org\/10.1097\/ccm.0000000000003779","journal-title":"Crit Care Med"},{"issue":"26","key":"8628_CR28","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1056\/nejmoa2202707","volume":"386","author":"TS Meyhoff","year":"2022","unstructured":"Meyhoff TS, Hjortrup PB, Wetterslev J, Sivapalan P, Laake JH, Cronhjort M et al (2022) Restriction of intravenous fluid in ICU patients with septic shock. N Engl J Med 386(26):2459\u20132470. https:\/\/doi.org\/10.1056\/nejmoa2202707","journal-title":"N Engl J Med"},{"issue":"19","key":"8628_CR29","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1056\/nejmoa010307","volume":"345","author":"E Rivers","year":"2001","unstructured":"Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345(19):1368\u20131377. https:\/\/doi.org\/10.1056\/nejmoa010307","journal-title":"N Engl J Med"},{"issue":"6","key":"8628_CR30","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1056\/nejmoa2212663","volume":"388","author":"NI Shapiro","year":"2023","unstructured":"Shapiro NI, Douglas IS, Brower RG, Brown SM, Exline MC, Ginde AA et al (2023) Early restrictive or liberal fluid management for sepsis-induced hypotension. N Engl J Med 388(6):499\u2013510. https:\/\/doi.org\/10.1056\/nejmoa2212663","journal-title":"N Engl J Med"},{"issue":"24","key":"8628_CR31","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1056\/nejmoa062200","volume":"354","author":"HP Wiedemann","year":"2006","unstructured":"Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B et al (2006) Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 354(24):2564\u20132575. https:\/\/doi.org\/10.1056\/nejmoa062200","journal-title":"N Engl J Med"},{"issue":"1","key":"8628_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-021-03495-8","volume":"25","author":"BL Erstad","year":"2021","unstructured":"Erstad BL, Barletta JF (2021) Drug dosing in the critically ill obese patient: a focus on medications for hemodynamic support and prophylaxis. Crit Care 25(1):77. https:\/\/doi.org\/10.1186\/s13054-021-03495-8","journal-title":"Crit Care"},{"issue":"12","key":"8628_CR33","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1177\/10600280211007213","volume":"55","author":"CA Dubrawka","year":"2021","unstructured":"Dubrawka CA, Betthauser KD, Pope HE, Gibson GA (2021) Effect of vasopressin dose on hemodynamic response in obese patients with septic shock: A retrospective observational study. Ann Pharmacother 55(12):1447\u20131454. https:\/\/doi.org\/10.1177\/10600280211007213","journal-title":"Ann Pharmacother"},{"issue":"Suppl 3","key":"8628_CR34","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1093\/ajhp\/zxac156","volume":"79","author":"M Lenney","year":"2022","unstructured":"Lenney M, Kopp B, Erstad B (2022) Effect of fixed-dose hydrocortisone on vasopressor dose and mean arterial pressure in obese and nonobese patients with septic shock. Am J Health Syst Pharm 79(Suppl 3):S94\u2013s99. https:\/\/doi.org\/10.1093\/ajhp\/zxac156","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"8628_CR35","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1128\/aac.01083-12","volume":"57","author":"M Hites","year":"2013","unstructured":"Hites M, Taccone FS, Wolff F, Cotton F, Beumier M, De Backer D et al (2013) Case-control study of drug monitoring of \u03b2-lactams in obese critically ill patients. Antimicrob Agents Chemother 57(2):708\u2013715. https:\/\/doi.org\/10.1128\/aac.01083-12","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"8628_CR36","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1038\/nutd.2014.15","volume":"4","author":"M Hites","year":"2014","unstructured":"Hites M, Taccone FS, Wolff F, Maillart E, Beumier M, Surin R et al (2014) Broad-spectrum \u03b2-lactams in obese non-critically ill patients. Nutr Diab 4(6):e119. https:\/\/doi.org\/10.1038\/nutd.2014.15","journal-title":"Nutr Diab"},{"issue":"3","key":"8628_CR37","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s11695-011-0586-8","volume":"22","author":"BS Rich","year":"2012","unstructured":"Rich BS, Keel R, Ho VP, Turbendian H, Afaneh CI, Dakin GF et al (2012) Cefepime dosing in the morbidly obese patient population. Obes Surg 22(3):465\u2013471. https:\/\/doi.org\/10.1007\/s11695-011-0586-8","journal-title":"Obes Surg"},{"issue":"5","key":"8628_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106151","volume":"56","author":"J Liu","year":"2020","unstructured":"Liu J, Rhodes NJ, Roberts JA, Pais GM, Turner B, Kiel PJ et al (2020) \u03b2-lactam dosing strategies: Think before you push. Int J Antimicrob Agents 56(5):106151. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106151","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"8628_CR39","doi-asserted-by":"publisher","first-page":"e01619","DOI":"10.1128\/aac.01619-20","volume":"65","author":"AL Blackman","year":"2021","unstructured":"Blackman AL, Jarugula P, Nicolau DP, Chui SH, Joshi M, Heil EL et al (2021) Evaluation of linezolid pharmacokinetics in critically Ill obese patients with severe skin and soft tissue infections. Antimicrob Agents Chemother 65(2):e01619\u2013e01620. https:\/\/doi.org\/10.1128\/aac.01619-20","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"8628_CR40","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s40262-017-0606-5","volume":"57","author":"P Cojutti","year":"2018","unstructured":"Cojutti P, Pai MP, Pea F (2018) Population pharmacokinetics and dosing considerations for the use of linezolid in overweight and obese adult patients. Clin Pharmacokinet 57(8):989\u20131000. https:\/\/doi.org\/10.1007\/s40262-017-0606-5","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"8628_CR41","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.cmi.2020.04.009","volume":"26","author":"L Ehmann","year":"2020","unstructured":"Ehmann L, Simon P, Busse D, Petroff D, Dorn C, Huisinga W et al (2020) Risk of target non-attainment in obese compared to non-obese patients in calculated linezolid therapy. Clin Microbiol Infect 26(9):1222\u20131228. https:\/\/doi.org\/10.1016\/j.cmi.2020.04.009","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"8628_CR42","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3390\/jcm9041067","volume":"9","author":"P Simon","year":"2020","unstructured":"Simon P, Busse D, Petroff D, Dorn C, Ehmann L, Hochst\u00e4dt S et al (2020) Linezolid concentrations in plasma and subcutaneous tissue are reduced in obese patients, resulting in a higher risk of underdosing in critically Ill patients: A controlled clinical pharmacokinetic study. J Clin Med 9(4):1067. https:\/\/doi.org\/10.3390\/jcm9041067","journal-title":"J Clin Med"},{"issue":"3","key":"8628_CR43","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1093\/jac\/dky500","volume":"74","author":"F Xie","year":"2019","unstructured":"Xie F, Mantzarlis K, Malliotakis P, Koulouras V, Degroote S, Koulenti D et al (2019) Pharmacokinetic evaluation of linezolid administered intravenously in obese patients with pneumonia. J Antimicrob Chemother 74(3):667\u2013674. https:\/\/doi.org\/10.1093\/jac\/dky500","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"8628_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-03040-z","volume":"24","author":"BL Erstad","year":"2020","unstructured":"Erstad BL, Barletta JF (2020) Drug dosing in the critically ill obese patient-a focus on sedation, analgesia, and delirium. Crit Care 24(1):315. https:\/\/doi.org\/10.1186\/s13054-020-03040-z","journal-title":"Crit Care"},{"issue":"3","key":"8628_CR45","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/00000542-200409000-00008","volume":"101","author":"K Shibutani","year":"2004","unstructured":"Shibutani K, Inchiosa MA, Sawada K, Bairamian M (2004) Accuracy of pharmacokinetic models for predicting plasma fentanyl concentrations in lean and obese surgical patients. Anesthesiology 101(3):603\u2013613. https:\/\/doi.org\/10.1097\/00000542-200409000-00008","journal-title":"Anesthesiology"},{"issue":"3","key":"8628_CR46","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/bja\/aei195","volume":"95","author":"K Shibutani","year":"2005","unstructured":"Shibutani K, Inchiosa MA, Sawada K, Bairamian M (2005) Pharmacokinetic mass of fentanyl for postoperative analgesia in lean and obese patients. Br J Anaesth 95(3):377\u2013383. https:\/\/doi.org\/10.1093\/bja\/aei195","journal-title":"Br J Anaesth"},{"issue":"3","key":"8628_CR47","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2165\/00003088-199733030-00005","volume":"33","author":"RN Upton","year":"1997","unstructured":"Upton RN, Semple TJ, Macintyre PE (1997) Pharmacokinetic optimisation of opioid treatment in acute pain therapy. Clin Pharmacokinet 33(3):225\u2013244. https:\/\/doi.org\/10.2165\/00003088-199733030-00005","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"8628_CR48","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1381\/096089202321144522","volume":"12","author":"DJ Scholten","year":"2002","unstructured":"Scholten DJ, Hoedema RM, Scholten SE (2002) A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Obes Surg 12(1):19\u201324. https:\/\/doi.org\/10.1381\/096089202321144522","journal-title":"Obes Surg"},{"issue":"1","key":"8628_CR49","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1160\/th13-01-0042","volume":"111","author":"TF Wang","year":"2014","unstructured":"Wang TF, Milligan PE, Wong CA, Deal EN, Thoelke MS, Gage BF (2014) Efficacy and safety of high-dose thromboprophylaxis in morbidly obese inpatients. Thromb Haemost 111(1):88\u201393. https:\/\/doi.org\/10.1160\/th13-01-0042","journal-title":"Thromb Haemost"},{"issue":"2","key":"8628_CR50","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ccc.2025.11.002","volume":"42","author":"JF Barletta","year":"2026","unstructured":"Barletta JF, Dzierba AL (2026) Pharmacists in interprofessional critical care: Optimizing medication management. Crit Care Clin 42(2):307\u2013327. https:\/\/doi.org\/10.1016\/j.ccc.2025.11.002","journal-title":"Crit Care Clin"},{"key":"8628_CR51","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/archinte.1916.00080130010002","volume":"17","author":"D Du Bois","year":"1916","unstructured":"Du Bois D, Du Bois EF (1916) Clinical calorimetry. Tenth paper. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 17:863. https:\/\/doi.org\/10.1001\/archinte.1916.00080130010002","journal-title":"Arch Intern Med"},{"issue":"17","key":"8628_CR52","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/nejm198710223171717","volume":"317","author":"RD Mosteller","year":"1987","unstructured":"Mosteller RD (1987) Simplified calculation of body-surface area. N Engl J Med 317(17):1098. https:\/\/doi.org\/10.1056\/nejm198710223171717","journal-title":"N Engl J Med"},{"key":"8628_CR53","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1177\/106002807400801104","volume":"8","author":"BJ Devine","year":"1974","unstructured":"Devine BJ (1974) Case number 25: gentamicin therapy. Drug Intell Clin Pharm 8:650\u2013655. https:\/\/doi.org\/10.1177\/106002807400801104","journal-title":"Drug Intell Clin Pharm"},{"issue":"5","key":"8628_CR54","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/bf00542215","volume":"24","author":"LA Bauer","year":"1983","unstructured":"Bauer LA, Edwards WA, Dellinger EP, Simonowitz DA (1983) Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patients. Eur J Clin Pharm 24(5):643\u2013647. https:\/\/doi.org\/10.1007\/bf00542215","journal-title":"Eur J Clin Pharm"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-026-08628-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-026-08628-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-026-08628-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:04:07Z","timestamp":1792667047000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-026-08628-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":54,"alternative-id":["8628"],"URL":"https:\/\/doi.org\/10.1007\/s00134-026-08628-7","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"assertion":[{"value":"21 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JFB, consultant for Wolters Kluwer.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}